EMP3 promoter hypermethylation is prevalent in oligodendroglial tumors (63%) and in oligoastrocytomas (70%) upon astrocytic tumors (18%), as already reported [5, 7, 8, 13, 14, 16, 17]. Here, EMP3 is linked to oligodendroglial tumor.